| Indicators | Browse All

Oragenics, Inc. (OGEN)

Healthcare | Biotechnology | Lakewood Ranch, United States | NYSE American
0.44 USD 0.00 (-0.229%) ⇩ (Oct. 15, 2026, 3:59 p.m. EDT)

Short-term:★☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 7:46 a.m. EDT

The immediate outlook is severely compromised by a massive capital raise that sent the stock tumbling, leaving it trading near its 52-week low despite holding some technical support. The recent price action shows a lack of recovery momentum, with the stock struggling to breach key moving averages while facing heavy short interest. Fundamentally, the picture is dire: the company has endured nearly a decade of consecutive annual declines, erasing almost 99.98% of its value over the last nine years. This multi-year structural deterioration, combined with negative earnings, negative free cash flow, and a forward P/E that indicates no expected profitability, suggests the market has priced out any hope of a turnaround. With no dividend to provide income and a balance sheet showing significant operational burn, the investment case is currently non-existent.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.036048
AutoARIMA0.036066
MSTL0.037654
AutoTheta0.046518

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 51%
H-stat 0.68
Ljung-Box p 0.000
Jarque-Bera p 0.421
Excess Kurtosis -0.91
Attribute Value
Sector Healthcare
Market Cap 1,890,508
Forward P/E -0.04
Beta 1.26
Website https://www.oragenics.com

Info Dump

Attribute Value
52 Week Change -0.6507937
Address1 9,015 Town Center Parkway
Address2 Suite 143
All Time High 1,620,000.0
All Time Low 0.43
Ask 0.0
Ask Size 200
Average Daily Volume10 Day 21,760
Average Daily Volume3 Month 29,459
Average Volume 29,459
Average Volume10Days 21,760
Beta 1.263
Bid 0.4
Bid Size 8,700
Book Value 0.814
City Lakewood Ranch
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.436
Current Ratio 3.015
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 0.4599
Day Low 0.43
Display Name Oragenics
Dividend Date 1,516,579,200
Dividend Yield 0.0
Earnings Timestamp End 1,754,942,400
Earnings Timestamp Start 1,754,596,800
Ebitda Margins 0.0
Enterprise Value -1,896,970
Eps Forward -10.8
Eps Trailing Twelve Months -2.44
Esg Populated 0
Exchange ASE
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 0.505
Fifty Day Average Change -0.069000006
Fifty Day Average Change Percent -0.13663368
Fifty Two Week Change Percent -65.07937
Fifty Two Week High 1.45
Fifty Two Week High Change -1.014
Fifty Two Week High Change Percent -0.69931036
Fifty Two Week Low 0.43
Fifty Two Week Low Change 0.0059999824
Fifty Two Week Low Change Percent 0.013953447
Fifty Two Week Range 0.43 - 1.45
Financial Currency USD
First Trade Date Milliseconds 1,077,719,400,000
Float Shares 4,424,876
Forward Eps -10.8
Forward P E -0.040370367
Free Cashflow -6,679,649
Full Exchange Name NYSE American
Full Time Employees 3
Fullday Change 0.0079
Fullday Change Percent 1.8077803
Fullday Price 0.436
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Gross Profits -3,423,534
Has Pre Post Market Data 1
Held Percent Insiders 0.01929
Held Percent Institutions 0.030620001
Implied Shares Outstanding 4,336,029
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Ir Website http://www.oragenics.com/?q=investors
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,748,908,800
Last Split Factor 1:30
Long Business Summary Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.
Long Name Oragenics, Inc.
Market us_market
Market Cap 1,890,508
Market State PRE
Max Age 86,400
Message Board Id finmb_774436
Most Recent Quarter 1,782,777,600
Net Income To Common -10,083,409
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 2,192,811
Open 0.4349
Operating Cashflow -10,207,331
Operating Margins 0.0
Payout Ratio 0.0
Peg Ratio -8.96
Phone 813 286 7900
Previous Close 0.437
Price Hint 4
Price To Book 0.53562653
Profit Margins 0.0
Quick Ratio 2.121
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.00100002
Regular Market Change Percent -0.228837
Regular Market Day High 0.4599
Regular Market Day Low 0.43
Regular Market Day Range 0.43 - 0.4599
Regular Market Open 0.4349
Regular Market Previous Close 0.437
Regular Market Price 0.436
Regular Market Time 1,792,094,351
Regular Market Volume 11,620
Return On Assets -1.71486
Return On Equity -13.07057
Sand P52 Week Change 0.16207206
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 4,336,029
Shares Percent Shares Out 0.1865
Shares Short 841,634
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 794,915
Short Name Oragenics Inc.
Short Percent Of Float 0.1867
Short Ratio 26.79
Source Interval 15
State FL
Symbol OGEN
Total Cash 3,864,184
Total Cash Per Share 0.856
Total Debt 0
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -2.44
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 0.63185
Two Hundred Day Average Change -0.19585001
Two Hundred Day Average Change Percent -0.30996284
Type Disp Equity
Volume 11,620
Website https://www.oragenics.com
Zip 34,202